Fluid-dynamics in Bifurcation PCI

Inclusion Criteria * Patients with stable or unstable coronary artery disease; * TIMI 3 on both MV and SB; * MV visual diameter \> 2.5 mm; * SB visual diameter \> 2.0 mm; * Documentation of angiographically-critical (visually estimated percentage diameter stenosis ≥80% \<100%) coronary lesion treated by PCI and underwent post-PCI OCT assessment or angiographically-intermediate (visually estimated percentage diameter stenosis ranging between 30-80%) lesion in the MV considered suitable for conservative management (myocardial revascularization not planned). Exclusion Criteria * Age \< 18 years or impossibility to give informed consent. * Female sex with child-bearing potential. * Life expectancy of less than 12 months or factors making clinical follow-up difficult (no fixed address, etc.). * Ascertained or suspected contraindications to prolonged (up to 6 month) double antiplatelet therapy. * Known hypersensitivity to aspirin, heparin, contrast dye, sirolimus, everolimus, zotarolimus, cobalt, chromium, nickel, tungsten acrylic, and fluoro-polymers. * Poor cardiac function as defined by left ventricular global ejection fraction ≤ 30%. * Recent (\< 48 hours) ST-segment elevation myocardial infarction. * Severe myocardial hypertrophy (interventricular septum thickness \> 15 mm, ECG Sokolow's criteria fulfilled). * Severe valvular heart disease. * Significant platelet count alteration (\<100,000 cells/mm3 or \> 700,000 cells/mm3). * Gastrointestinal bleeding requiring surgery or blood transfusions within 4 previous weeks. * History of clotting pathology. * Advance renal failure with glomerular filtration rate \< 30 ml/min (Cockcroft-Gault equation) * Left main lesion. * Target bifurcation located on a distal coronary segment.